-+ 0.00%
-+ 0.00%
-+ 0.00%

Insilico Medicine prices USD 305 million zero-coupon convertible bond offering due 2027

PUBT·08/27/2026 22:24:23
Listen to the news
Insilico Medicine prices USD 305 million zero-coupon convertible bond offering due 2027
  • Insilico Medicine priced a USD 305 million zero coupon convertible bonds due 2027 offering.
  • Bonds convert at an initial HKD 58.07 per share, a 23.5% premium to the Aug. 27 close.
  • Full conversion implies 41,174,737 new shares, about 6.6% of enlarged share capital.
  • Net proceeds estimated at about USD 301.6 million, earmarked mainly for clinical trials, R&D hiring, AI model development.
  • Bond closing targeted around Sept. 3, 2026; bonds to be listed on Vienna MTF.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Insilico Medicine Cayman Topco published the original content used to generate this news brief via IIS, the regulatory disclosure system operated by the Hong Kong Stock Exchange (HKex) (Ref. ID: HKEX-EPS-20260828-12303631), on August 27, 2026, and is solely responsible for the information contained therein.